Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees

Nilufer Ertekin-Taner, Neill Graff-Radford, Linda H. Younkin, Christopher Eckman, Jennifer Adamson, Daniel J. Schaid, John Blangero, Michael Hutton, Steven G. Younkin

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Plasma amyloid β42 peptide (Aβ42) levels are significantly elevated in all genetic forms of early-onset Alzheimer's disease caused by familial Alzheimer's disease mutations or Down's syndrome. Moreover, recent studies have determined that both plasma Aβ42 and Aβ40 levels are significantly elevated in late-onset Alzheimer's disease (LOAD) patients, their cognitively normal first-degree relatives, and members of typical LOAD families when compared to appropriate controls. To determine the magnitude of the genetic component affecting plasma Aβ levels, we estimated the heritability of plasma Aβ42 and Aβ40 in 15 extended, multigenerational LOAD pedigrees, using a variance components method. Heritability estimates as high as 73 and 54% were found for plasma Aβ42 and Aβ40 levels, respectively. Inclusion of the ApoE ε4 dosage as a covariate was not found to have a significant effect on the heritability of these traits. These results suggest that genetic determinants other than ApoE account for a very substantial percentage of the phenotypic variance in plasma Aβ levels. The high heritability and the significant elevation of these traits in LOAD pedigrees suggest that at least some of the genetic determinants of plasma Aβ levels may lead to elevated Aβ and LOAD in these families. Thus, we suggest that plasma Aβ levels are quantitative traits that may be excellent surrogate markers for use in linkage analysis to identify loci that are important in typical LOAD.

Original languageEnglish (US)
Pages (from-to)19-30
Number of pages12
JournalGenetic Epidemiology
Volume21
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Pedigree
Amyloid
Alzheimer Disease
Peptides
Apolipoproteins E
Down Syndrome
Biomarkers
Mutation

Keywords

  • Alzheimer's disease
  • Amyloid β
  • Heritability
  • Surrogate marker

ASJC Scopus subject areas

  • Genetics(clinical)
  • Epidemiology

Cite this

Ertekin-Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C., Adamson, J., Schaid, D. J., ... Younkin, S. G. (2001). Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees. Genetic Epidemiology, 21(1), 19-30. https://doi.org/10.1002/gepi.1015

Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees. / Ertekin-Taner, Nilufer; Graff-Radford, Neill; Younkin, Linda H.; Eckman, Christopher; Adamson, Jennifer; Schaid, Daniel J.; Blangero, John; Hutton, Michael; Younkin, Steven G.

In: Genetic Epidemiology, Vol. 21, No. 1, 2001, p. 19-30.

Research output: Contribution to journalArticle

Ertekin-Taner, N, Graff-Radford, N, Younkin, LH, Eckman, C, Adamson, J, Schaid, DJ, Blangero, J, Hutton, M & Younkin, SG 2001, 'Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees', Genetic Epidemiology, vol. 21, no. 1, pp. 19-30. https://doi.org/10.1002/gepi.1015
Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Adamson J, Schaid DJ et al. Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees. Genetic Epidemiology. 2001;21(1):19-30. https://doi.org/10.1002/gepi.1015
Ertekin-Taner, Nilufer ; Graff-Radford, Neill ; Younkin, Linda H. ; Eckman, Christopher ; Adamson, Jennifer ; Schaid, Daniel J. ; Blangero, John ; Hutton, Michael ; Younkin, Steven G. / Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees. In: Genetic Epidemiology. 2001 ; Vol. 21, No. 1. pp. 19-30.
@article{c4432d627a6c417ea2fbea4036b377d0,
title = "Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees",
abstract = "Plasma amyloid β42 peptide (Aβ42) levels are significantly elevated in all genetic forms of early-onset Alzheimer's disease caused by familial Alzheimer's disease mutations or Down's syndrome. Moreover, recent studies have determined that both plasma Aβ42 and Aβ40 levels are significantly elevated in late-onset Alzheimer's disease (LOAD) patients, their cognitively normal first-degree relatives, and members of typical LOAD families when compared to appropriate controls. To determine the magnitude of the genetic component affecting plasma Aβ levels, we estimated the heritability of plasma Aβ42 and Aβ40 in 15 extended, multigenerational LOAD pedigrees, using a variance components method. Heritability estimates as high as 73 and 54{\%} were found for plasma Aβ42 and Aβ40 levels, respectively. Inclusion of the ApoE ε4 dosage as a covariate was not found to have a significant effect on the heritability of these traits. These results suggest that genetic determinants other than ApoE account for a very substantial percentage of the phenotypic variance in plasma Aβ levels. The high heritability and the significant elevation of these traits in LOAD pedigrees suggest that at least some of the genetic determinants of plasma Aβ levels may lead to elevated Aβ and LOAD in these families. Thus, we suggest that plasma Aβ levels are quantitative traits that may be excellent surrogate markers for use in linkage analysis to identify loci that are important in typical LOAD.",
keywords = "Alzheimer's disease, Amyloid β, Heritability, Surrogate marker",
author = "Nilufer Ertekin-Taner and Neill Graff-Radford and Younkin, {Linda H.} and Christopher Eckman and Jennifer Adamson and Schaid, {Daniel J.} and John Blangero and Michael Hutton and Younkin, {Steven G.}",
year = "2001",
doi = "10.1002/gepi.1015",
language = "English (US)",
volume = "21",
pages = "19--30",
journal = "Genetic Epidemiology",
issn = "0741-0395",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Heritability of plasma amyloid β in typical late-onset Alzheimer's disease pedigrees

AU - Ertekin-Taner, Nilufer

AU - Graff-Radford, Neill

AU - Younkin, Linda H.

AU - Eckman, Christopher

AU - Adamson, Jennifer

AU - Schaid, Daniel J.

AU - Blangero, John

AU - Hutton, Michael

AU - Younkin, Steven G.

PY - 2001

Y1 - 2001

N2 - Plasma amyloid β42 peptide (Aβ42) levels are significantly elevated in all genetic forms of early-onset Alzheimer's disease caused by familial Alzheimer's disease mutations or Down's syndrome. Moreover, recent studies have determined that both plasma Aβ42 and Aβ40 levels are significantly elevated in late-onset Alzheimer's disease (LOAD) patients, their cognitively normal first-degree relatives, and members of typical LOAD families when compared to appropriate controls. To determine the magnitude of the genetic component affecting plasma Aβ levels, we estimated the heritability of plasma Aβ42 and Aβ40 in 15 extended, multigenerational LOAD pedigrees, using a variance components method. Heritability estimates as high as 73 and 54% were found for plasma Aβ42 and Aβ40 levels, respectively. Inclusion of the ApoE ε4 dosage as a covariate was not found to have a significant effect on the heritability of these traits. These results suggest that genetic determinants other than ApoE account for a very substantial percentage of the phenotypic variance in plasma Aβ levels. The high heritability and the significant elevation of these traits in LOAD pedigrees suggest that at least some of the genetic determinants of plasma Aβ levels may lead to elevated Aβ and LOAD in these families. Thus, we suggest that plasma Aβ levels are quantitative traits that may be excellent surrogate markers for use in linkage analysis to identify loci that are important in typical LOAD.

AB - Plasma amyloid β42 peptide (Aβ42) levels are significantly elevated in all genetic forms of early-onset Alzheimer's disease caused by familial Alzheimer's disease mutations or Down's syndrome. Moreover, recent studies have determined that both plasma Aβ42 and Aβ40 levels are significantly elevated in late-onset Alzheimer's disease (LOAD) patients, their cognitively normal first-degree relatives, and members of typical LOAD families when compared to appropriate controls. To determine the magnitude of the genetic component affecting plasma Aβ levels, we estimated the heritability of plasma Aβ42 and Aβ40 in 15 extended, multigenerational LOAD pedigrees, using a variance components method. Heritability estimates as high as 73 and 54% were found for plasma Aβ42 and Aβ40 levels, respectively. Inclusion of the ApoE ε4 dosage as a covariate was not found to have a significant effect on the heritability of these traits. These results suggest that genetic determinants other than ApoE account for a very substantial percentage of the phenotypic variance in plasma Aβ levels. The high heritability and the significant elevation of these traits in LOAD pedigrees suggest that at least some of the genetic determinants of plasma Aβ levels may lead to elevated Aβ and LOAD in these families. Thus, we suggest that plasma Aβ levels are quantitative traits that may be excellent surrogate markers for use in linkage analysis to identify loci that are important in typical LOAD.

KW - Alzheimer's disease

KW - Amyloid β

KW - Heritability

KW - Surrogate marker

UR - http://www.scopus.com/inward/record.url?scp=0034936365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034936365&partnerID=8YFLogxK

U2 - 10.1002/gepi.1015

DO - 10.1002/gepi.1015

M3 - Article

C2 - 11443731

AN - SCOPUS:0034936365

VL - 21

SP - 19

EP - 30

JO - Genetic Epidemiology

JF - Genetic Epidemiology

SN - 0741-0395

IS - 1

ER -